WASHINGTON (AP) — Long-awaited studies of two possible Ebola vaccines are set to begin in West Africa in a few weeks, starting in Liberia, U.S. officials said...
Subscribe Today!
Story Tags:
Anthony Fauci
Ebola
Liberia
United States
Sierra Leone
Sierra Leone
West Africa
WASHINGTON
GlaxoSmithKline
Mapp Biopharmaceutical Inc.
Merck
NewLink Genetics
Guinea
National Institute
immune systems
allergy
infectious diseases
New infections
several Ebola
non-infectious Ebola
National Institute of Health
World Health Organization
National Institute
National Center for Immunization and Respiratory Diseases
